HRP-Linked Polyclonal Antibody to Structure Specific Recognition Protein 1 (SSRP1)
Cat# MBS2042224-0,5mL
Size : 0.5mL
Brand : MyBiosource
Contact local distributor :
Phone : +1 850 650 7790
Structure Specific Recognition Protein 1 (SSRP1) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2042224SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2042224 is an antibody targeting SSRP1. Also known as HRP-Linked Polyclonal Antibody to Structure Specific Recognition Protein 1 (SSRP1). Reactive in Human, Mouse, Rat. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Structure Specific Recognition Protein 1 (SSRP1), Polyclonal Antibody
Full Product Name
HRP-Linked Polyclonal Antibody to Structure Specific Recognition Protein 1 (SSRP1)
Product Gene Name
anti-SSRP1 antibody
Product Synonym Names
FACT; FACT80; T160; Facilitates Chromatin Remodeling 80 kDa Subunit; Recombination signal sequence recognition protein 1; Chromatin-specific transcription elongation factor 80
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human, Mouse, Rat
Concentration
500ug/ml (lot specific)
Matching Pairs
Unconjugated Antibody: SSRP1 (MBS2027204)
HRP Conjugated Antibody: SSRP1 (MBS2042224)
HRP Conjugated Antibody: SSRP1 (MBS2042224)
Matching Pairs
HRP Conjugated Antibody: SSRP1 (MBS2042224)
Immunogen: SSRP1 (MBS2031105)
Immunogen: SSRP1 (MBS2031105)
Molecular Weight
81,075 Da
OMIM
M86737 mRNA
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Immunogen
SSRP1 (Glu6~Pro246)
Conjugation
HRP
Cross Reactivity
Human
Unconjugated Antibody
The unconjugated antibody version of this item is also available as catalog #MBS2027204
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-SSRP1 antibody
Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (ELISA)
Other Notes
Small volumes of anti-SSRP1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for SSRP1. It may not necessarily be applicable to this product.
NCBI Official Full Name
Structure specific recognition protein 1
NCBI Official Synonym Full Names
structure specific recognition protein 1
NCBI Official Symbol
SSRP1
NCBI Official Synonym Symbols
FACT; T160; FACT80
UniProt Protein Name
FACT complex subunit SSRP1
UniProt Synonym Protein Names
Chromatin-specific transcription elongation factor 80 kDa subunit; Facilitates chromatin transcription complex 80 kDa subunit; FACT 80 kDa subunit; FACTp80; Facilitates chromatin transcription complex subunit SSRP1; Recombination signal sequence recognition protein 1; Structure-specific recognition protein 1; hSSRP1; T160
UniProt Gene Name
SSRP1
UniProt Synonym Gene Names
FACT80; FACT 80 kDa subunit; FACTp80; hSSRP1
NCBI Protein Information
FACT complex subunit SSRP1
NCBI Summary for SSRP1
The protein encoded by this gene is a subunit of a heterodimer that, along with SUPT16H, forms chromatin transcriptional elongation factor FACT. FACT interacts specifically with histones H2A/H2B to effect nucleosome disassembly and transcription elongation. FACT and cisplatin-damaged DNA may be crucial to the anticancer mechanism of cisplatin. This encoded protein contains a high mobility group box which most likely constitutes the structure recognition element for cisplatin-modified DNA. This protein also functions as a co-activator of the transcriptional activator p63. An alternatively spliced transcript variant of this gene has been described, but its full-length nature is not known. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for SSRP1
SSRP1: a subunit of the chromatin transcriptional elongation factor FACT. FACT interacts specifically with histones H2A/H2B to effect nucleosome disassembly and transcription elongation. FACT and cisplatin-damaged DNA may be crucial to the anticancer mechanism of cisplatin. This encoded protein contains a high mobility group box which most likely constitutes the structure recognition element for cisplatin-modified DNA. This protein also functions as a co-activator of the transcriptional activator p63.
Protein type: Nucleolus; RNA-binding; Transcription initiation complex; Transcription, coactivator/corepressor
Chromosomal Location of Human Ortholog: 11q12.1
Cellular Component: cytoplasm; nucleoplasm; nucleus
Molecular Function: protein binding
Biological Process: RNA elongation from RNA polymerase II promoter; transcription from RNA polymerase II promoter
Show more Protein type: Nucleolus; RNA-binding; Transcription initiation complex; Transcription, coactivator/corepressor
Chromosomal Location of Human Ortholog: 11q12.1
Cellular Component: cytoplasm; nucleoplasm; nucleus
Molecular Function: protein binding
Biological Process: RNA elongation from RNA polymerase II promoter; transcription from RNA polymerase II promoter
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-SSRP1 antibody
| Reference Product | PubMed Publications |
|---|---|
| SUPT16H antibody | >19 publications with SSRP1 and SUPT16H |
| CHD1 antibody | >2 publications with SSRP1 and CHD1 |
| SUPT4H1 antibody | >1 publications with SSRP1 and SUPT4H1 |
| MCM4 antibody | >1 publications with SSRP1 and MCM4 |
| MCM2 antibody | >1 publications with SSRP1 and MCM2 |
Pathways associated with anti-SSRP1 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Disease Pathway antibodies | Disease Pathway Diagram |
| Formation Of HIV Elongation Complex In The Absence Of HIV Tat Pathway antibodies | Formation Of HIV Elongation Complex In The Absence Of HIV Tat Pathway Diagram |
| Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat Pathway antibodies | Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat Pathway Diagram |
| Formation Of RNA Pol II Elongation Complex Pathway antibodies | Formation Of RNA Pol II Elongation Complex Pathway Diagram |
| Gene Expression Pathway antibodies | Gene Expression Pathway Diagram |
| HIV Infection Pathway antibodies | HIV Infection Pathway Diagram |
| HIV Life Cycle Pathway antibodies | HIV Life Cycle Pathway Diagram |
| HIV Transcription Elongation Pathway antibodies | HIV Transcription Elongation Pathway Diagram |
| HIV Elongation Arrest And Recovery Pathway antibodies | HIV Elongation Arrest And Recovery Pathway Diagram |
| Late Phase Of HIV Life Cycle Pathway antibodies | Late Phase Of HIV Life Cycle Pathway Diagram |
Diseases associated with anti-SSRP1 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Death Antibodies | >5 publications with SSRP1 and Death |
| Cell Transformation, Neoplastic Antibodies | >3 publications with SSRP1 and Cell Transformation, Neoplastic |
| Skin Diseases Antibodies | >2 publications with SSRP1 and Skin Diseases |
| Immune System Diseases Antibodies | >2 publications with SSRP1 and Immune System Diseases |
| Disease Models, Animal Antibodies | >2 publications with SSRP1 and Disease Models, Animal |
| Necrosis Antibodies | >2 publications with SSRP1 and Necrosis |
| Nervous System Diseases Antibodies | >1 publications with SSRP1 and Nervous System Diseases |
| Urinary Bladder Neoplasms Antibodies | >1 publications with SSRP1 and Urinary Bladder Neoplasms |
| Liver Neoplasms Antibodies | >1 publications with SSRP1 and Liver Neoplasms |
| Neoplasms, Experimental Antibodies | >1 publications with SSRP1 and Neoplasms, Experimental |
Organs/Tissues associated with anti-SSRP1 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >8 publications with SSRP1 and Blood |
| Muscle Antibodies | >5 publications with SSRP1 and Muscle |
| Lung Antibodies | >3 publications with SSRP1 and Lung |
| Kidney Antibodies | >2 publications with SSRP1 and Kidney |
| Vascular Antibodies | >1 publications with SSRP1 and Vascular |
| Liver Antibodies | >1 publications with SSRP1 and Liver |
| Bladder Antibodies | >1 publications with SSRP1 and Bladder |
| Brain Antibodies | >1 publications with SSRP1 and Brain |
| Embryonic Tissue Antibodies | >1 publications with SSRP1 and Embryonic Tissue |